Expert US Breast Cancer Specialist Second Opinion, Remotely

A breast cancer diagnosis demands the highest level of expertise, especially when treatment decisions involve surgery, hormonal therapy, HER2-targeted agents, or BRCA-related genetic considerations. Seeking a breast cancer specialist second opinion from a US cancer center ensures you have the most current clinical perspective before treatment begins.

Medebound Health facilitates remote second opinions from board-certified breast oncologists at institutions such as Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, MD Anderson Cancer Center, and Mayo Clinic. These specialists are routinely involved in landmark breast cancer clinical trials and have deep expertise in luminal A/B subtypes, triple-negative breast cancer, and HER2-positive disease.

After you securely upload your pathology reports, hormone receptor and HER2 status results, imaging studies, and prior treatment history, a dedicated breast cancer specialist reviews your case. The written second opinion report — delivered within 5–7 days — covers diagnosis accuracy, staging confirmation, and treatment recommendations. A follow-up video consultation lets you ask questions directly.

Since 2016, Medebound Health has helped more than 3,000 international patients access specialist-level breast cancer guidance without leaving their home country. Our care team speaks multiple languages and handles all document coordination on your behalf.

Whether you want to confirm a mastectomy recommendation, explore neoadjuvant chemotherapy options, or understand your eligibility for a clinical trial, a breast cancer specialist second opinion from a top US oncologist gives you the clarity you deserve. Contact Medebound Health now to start your case.

Frequently Asked Questions

Can I get a breast cancer second opinion without traveling to the US?
Yes. Medebound Health provides fully remote breast cancer second opinions. You upload your medical records securely, and a US breast cancer specialist reviews your case and delivers a written report plus video consultation within 5–7 days.

What breast cancer subtypes can be reviewed in a US second opinion?
US oncologists through Medebound Health review all subtypes, including ER/PR-positive, HER2-positive, triple-negative, and BRCA-associated breast cancers, at any stage.

How much does a breast cancer second opinion from a US specialist cost?
Medebound Health's remote second opinion service is priced between $2,000 and $5,000 depending on case complexity — significantly less than the cost of traveling to the US for an in-person consultation.